Rigaku收购Emerald Bio结晶试剂和耗材业务

    


2013年7月31日 位于美国伍德兰德斯的理学美国公司(Rigaku Americas Corporation)宣布，公司已经收购了Emerald Bio的结晶试剂和耗材业务，包括结晶筛选工具。Emerald Bio位于华盛顿班布里奇岛。两家公司已经同意共同开发蛋白质科学领域的新产品和解决方案。

　　“收购耗材和筛选工具业务是增加与我们仪器客户更多接触、提高他们工作效率的一个步骤，” 理学美国公司生命科学部门总裁Catherine Klein说。“此外，Emerald Bio成为我们的发展伙伴，将有助于确保我们的新产品位于蛋白质科学研究的最前沿。”

　　“世界领先的蛋白质结晶学仪器公司Rigaku是Emerald Bio理想的发展伙伴，”Emerald Bio首席执行官Johan Pontin说。

Rigaku and Emerald Bio Announce Strategic Alliance to Broaden Customer Solutions in Protein Crystallography

Rigaku Corporation, has developed a new partnership in the field of protein science with Emerald Bio, acquiring their crystallization reagent and consumable business.

 

The Woodlands, TX (PRWEB) July 31, 2013

Rigaku, the leading supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallization reagent and consumable business, including the popular Wizard™ screens, from Emerald Bio, a world leader in protein science. In addition, both companies have agreed to work together to develop new products and solutions in the growing field of protein science.

“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” stated Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division. “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”

“Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for Emerald,” said Johan Pontin, CEO of Emerald Bio. “While we focus on our growing consulting solutions business,” said George Abe, president of Emerald Bio, “we can rely on Rigaku to support our own internal workflow needs and we now have a partner to build integrated solutions, including software, for our mutual customers.”

About Rigaku: 
Since its inception in Japan in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Rigaku and its subsidiaries form a global group focused on life sciences and general purpose analytical instrumentation. With hundreds of major innovations to its credit, Rigaku and its subsidiary companies are world leaders in the fields of small molecule and protein crystallography, X-ray spectrometry and diffraction, X-ray optics, as well as semiconductor metrology. Rigaku employs over 1,100 people in the manufacture and support of its analytical equipment. Its products are in use in more than 70 countries – supporting research, development, and quality assurance activities. Throughout the world, Rigaku continuously promotes partnerships, dialog, and innovation within the global scientific and industrial community.

For further information, contact:

Dr. Michael Willis 
Rigaku 
760-438-5282 x106 
michael.willis(at)rigaku(dot)com

About Emerald: 
Emerald Bio, The Protein Resource, operates as a contract research organization with vertical expertise in structural biology and protein resourcing. Emerald Bio offers structure-based drug discovery insight and expertise, innovative workflows, cutting edge specialty reagents and software to help solve our clients’ challenges connecting structure and function in protein science. We leverage our unique assets and know-how in biochemistry and structural biology to further our client’s understanding of proteins that ultimately leads to improved human health. Emerald Bio is a privately owned company that maintains facilities in Seattle and Boston. Emerald Bio is rapidly establishing itself as a leading global company in the area of membrane protein biology and chemistry, supporting leading research institutes with membrane protein tools and solutions that advance its customer’s scientific objectives.

For more information contact:

George Abe 
Emerald Bio 
781-652-4002 
gabe(at)embios(dot)com